CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

被引:39
|
作者
Tobaly, David [1 ]
Santinha, Joao [2 ,3 ]
Sartoris, Riccardo [1 ,4 ]
Dioguardi Burgio, Marco [1 ,4 ]
Matos, Celso [5 ,6 ]
Cros, Jerome [7 ]
Couvelard, Anne [8 ]
Rebours, Vinciane [9 ]
Sauvanet, Alain [10 ]
Ronot, Maxime [1 ,4 ]
Papanikolaou, Nikolaos [11 ]
Vilgrain, Valerie [1 ,4 ]
机构
[1] Hop Beaujon, AP HP Nord, AP HP, Serv Radiol, F-92110 Clichy, France
[2] Champalimaud Fdn, Champalimaud Res, Computat Clin Imaging Grp, Ave Brasilia, P-1400038 Lisbon, Portugal
[3] Univ Lisbon, Inst Super Tecn, Inst Telecomunicacoes, P-1049001 Lisbon, Portugal
[4] Univ Paris, INSERM, U1149, Ctr Rech Inflammat Cri, F-75018 Paris, France
[5] Champalimaud Fdn, Radiol Dept, Ave Brasilia, P-1400038 Lisbon, Portugal
[6] Champalimaud Fdn, Champalimaud Res, Ave Brasilia, P-1400038 Lisbon, Portugal
[7] Hop Beaujon, AP HP Nord, AP HP, Serv Anatomopathol, F-92110 Clichy, France
[8] Hop Bichat Claude Bernard, AP HP Nord, AP HP, Serv Anatomopathol, F-75018 Paris, France
[9] Hop Beaujon, AP HP Nord, AP HP, Serv Pancreatol, F-92110 Clichy, France
[10] Hop Beaujon, AP HP Nord, AP HP, Serv Chirurg HPB, F-92110 Clichy, France
[11] Champalimaud Fdn, Champalimaud Res, Computat Clin Imaging Grp, P-1400038 Lisbon, Portugal
关键词
risk stratification; quantitative imaging; texture; malignant transformation; radiomics; pancreatic cyst; INTERNATIONAL CONSENSUS GUIDELINES; PHASE HELICAL CT; IMAGING FEATURES; MANAGEMENT; CYSTS; PERFORMANCE; PREVALENCE; DIAGNOSIS; SYSTEM;
D O I
10.3390/cancers12113089
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The management of intraductal papillary mucinous neoplasms of the pancreas (IPMN) remains controversial due to the relatively high rate of unnecessary surgery for low grade dysplasia (LGD) despite the last international recommendations. The aim of our retrospective study was to assess the performance of radiomic analysis on CT in differentiating benign from malignant IPMN. We confirmed in a training cohort (296 patients) and a validation cohort (112 patients) that a total of 85 radiomics features provided valuable additional and independent information for discriminating benign from malignant tumors in the training cohort with an area under the ROC curve (AUC) of 0.84 and an external validation with an AUC of 0.71 with higher performance when implementing clinical variables leading to the indication to surgery. We have demonstrated the capabilities of radiomics models comprising LGD versus high-grade dysplasia (HGD) versus invasive, LGD and HGD, HGD and invasive. To assess the performance of CT-based radiomics analysis in differentiating benign from malignant intraductal papillary mucinous neoplasms of the pancreas (IPMN), preoperative scans of 408 resected patients with IPMN were retrospectively analyzed. IPMNs were classified as benign (low-grade dysplasia, n = 181), or malignant (high grade, n = 128, and invasive, n = 99). Clinicobiological data were reported. Patients were divided into a training cohort (TC) of 296 patients and an external validation cohort (EVC) of 112 patients. After semi-automatic tumor segmentation, PyRadiomics was used to extract radiomics features. A multivariate model was developed using a logistic regression approach. In the training cohort, 85/107 radiomics features were significantly different between patients with benign and malignant IPMNs. Unsupervised clustering analysis revealed four distinct clusters of patients with similar radiomics features patterns with malignancy as the most significant association. The multivariate model differentiated benign from malignant tumors in TC with an area under the ROC curve (AUC) of 0.84, sensitivity (Se) of 0.82, specificity (Spe) of 0.74, and in EVC with an AUC of 0.71, Se of 0.69, Spe of 0.57. This large study confirms the high diagnostic performance of preoperative CT-based radiomics analysis to differentiate between benign from malignant IPMNs.
引用
收藏
页码:1 / 19
页数:19
相关论文
共 50 条
  • [1] Pathological Markers Which Predict Malignancy of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
    Nakahodo, J.
    Fukumura, Y.
    Yanai, Y.
    Tsuyama, S.
    Mamat, O.
    Mitomi, H.
    Isayama, H.
    Kawasaki, S.
    Yao, T.
    PANCREAS, 2017, 46 (10) : 1422 - 1422
  • [2] Mucinous biliary obstruction in intraductal papillary mucinous neoplasm of the pancreas (IPMN)
    Trigg, NA
    El-Attar, A
    Berkelhammer, C
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S233 - S233
  • [3] Surgical Management of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
    Michael B. Farnell
    Journal of Gastrointestinal Surgery, 2008, 12 : 414 - 416
  • [4] Surgical management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas
    Farnell, Michael B.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (03) : 414 - 416
  • [5] Intraductal Papillary Mucinous Neoplasm of the Pancreas (IPMN) - Standards and New Aspects
    Distler, M.
    Welsch, T.
    Aust, D.
    Weitz, J.
    Gruetzmann, R.
    ZENTRALBLATT FUR CHIRURGIE, 2014, 139 (03): : 308 - 317
  • [6] Colloid Carcinoma of Pancreas in the Setting of Intraductal Papillary Mucinous Neoplasm (IPMN)
    Thejus Jayakrishnan
    Dhwani Pandya
    Dulabh Monga
    Journal of Gastrointestinal Cancer, 2020, 51 : 658 - 662
  • [7] Colloid Carcinoma of Pancreas in the Setting of Intraductal Papillary Mucinous Neoplasm (IPMN)
    Jayakrishnan, Thejus
    Pandya, Dhwani
    Monga, Dulabh
    JOURNAL OF GASTROINTESTINAL CANCER, 2020, 51 (02) : 658 - 662
  • [8] Are Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of Pancreas Likely to Carry Colorectal Neoplasia?
    Ishikawa, Shin
    Kato, Jun
    Suzuki, Hideyuki
    Horii, Joichiro
    Saito, Shunsuke
    Higashi, Reiji
    Hirao, Ken
    Kato, Hironari
    Kuriyama, Motoaki
    Kaji, Eisuke
    Uraoka, Toshio
    Hiraoka, Sakiko
    Yamamoto, Kazuhide
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB289 - AB290
  • [9] Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
    Gambaccini, Dario
    Bellini, Massimo
    Luglio, Giuseppe
    Russo, Salvatore
    Battaglia, Valentina
    Maltinti, Simona
    Albano, Eleonora
    Giannotti, Sandro
    Spisni, Roberto
    de Bortoli, Nicola
    Marchi, Santino
    GASTROENTEROLOGY, 2016, 150 (04) : S507 - S508
  • [10] Pathohistological Subtype Predicts Survival in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
    Distler, Marius
    Kersting, Stephan
    Niedergethmann, Marco
    Aust, Daniela E.
    Franz, Melanie
    Rueckert, Felix
    Ehehalt, Florian
    Pilarsky, Christian
    Post, Stefan
    Saeger, Hans-Detlev
    Gruetzmann, Robert
    ANNALS OF SURGERY, 2013, 258 (02) : 324 - 330